Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Total Liabilities (2017 - 2024)

Solid Biosciences' Total Liabilities history spans 8 years, with the latest figure at $44.8 million for Q3 2024.

  • For Q3 2024, Total Liabilities rose 10.99% year-over-year to $44.8 million; the TTM value through Sep 2024 reached $44.8 million, up 10.99%, while the annual FY2023 figure was $38.5 million, 20.85% down from the prior year.
  • Total Liabilities for Q3 2024 was $44.8 million at Solid Biosciences, up from $37.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $48.6 million in Q4 2022 and bottomed at $17.2 million in Q2 2020.
  • The 5-year median for Total Liabilities is $38.0 million (2024), against an average of $34.0 million.
  • The largest annual shift saw Total Liabilities crashed 38.16% in 2021 before it soared 107.76% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $39.1 million in 2020, then plummeted by 38.16% to $24.2 million in 2021, then skyrocketed by 101.03% to $48.6 million in 2022, then decreased by 20.85% to $38.5 million in 2023, then increased by 16.5% to $44.8 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Total Liabilities are $44.8 million (Q3 2024), $37.7 million (Q2 2024), and $38.0 million (Q1 2024).